Connection
Rose Gelineau-Morel to Humans
This is a "connection" page, showing publications Rose Gelineau-Morel has written about Humans.
|
|
Connection Strength |
|
|
|
|
|
0.849 |
|
|
|
-
Gelineau-Morel R, Usman F, Shehu S, Yeh HW, Suwaid MA, Abdulsalam M, Jibril Y, Satrom KM, Shapiro SM, Zinkus TP, Head HW, Slusher TM, Le Pichon JB, Farouk ZL. Predictive and diagnostic measures for kernicterus spectrum disorder: a prospective cohort study. Pediatr Res. 2024 Jan; 95(1):285-292.
Score: 0.092
-
Gelineau-Morel R, Smyser C, Leeder JS. Identifying Effective Treatments for Dystonia in Patients With Cerebral Palsy: A Precision Therapeutics Approach. Neurology. 2023 10 24; 101(17):752-759.
Score: 0.091
-
Gelineau-Morel R, Kim YM, O'Malley JA, Wilson JL, Aravamuthan BR. The Role of Child Neurologists in the Management of Motor Disability in Cerebral Palsy: Establishing the Path Forward. Pediatr Neurol. 2023 07; 144:33-38.
Score: 0.090
-
Gelineau-Morel R, Kruer MC, Garris JF, Abu Libdeh A, Barbosa DAN, Coffman KA, Moon D, Barton C, Zea Vera A, Bruce AB, Larsh T, Wu SW, Gilbert DL, O'Malley JA. Deep Brain Stimulation for Pediatric Dystonia: A Review of the Literature and Suggested Programming Algorithm. J Child Neurol. 2022 10; 37(10-11):813-824.
Score: 0.086
-
Gelineau-Morel R. Rose Gelineau-Morel, MD: Early Career Investigator-March 2022. Pediatr Res. 2022 03; 91(4):724.
Score: 0.082
-
Dasari VR, Shapiro SM, Yeh HW, Gelineau-Morel R. Kernicterus Spectrum Disorders Diagnostic Toolkit: validation using retrospective chart review. Pediatr Res. 2022 03; 91(4):862-866.
Score: 0.081
-
Gelineau-Morel R, Dilts J. Virtual Education During COVID-19 and Beyond. Pediatr Neurol. 2021 06; 119:1-2.
Score: 0.078
-
Gelineau-Morel RN, Zinkus TP, Le Pichon JB. Pediatric Head Trauma: A Review and Update. Pediatr Rev. 2019 Sep; 40(9):468-481.
Score: 0.070
-
Gelineau-Morel R, Tomassini V, Jenkinson M, Johansen-Berg H, Matthews PM, Palace J. The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapp. 2012 Dec; 33(12):2802-14.
Score: 0.040
-
Lott E, Fehlings D, Gelineau-Morel R, Kruer M, Mink JW, Thomas SP, Wisniewski S, Aravamuthan B. Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy. Pediatrics. 2024 Jul 01; 154(1).
Score: 0.024
-
Cohen ASA, Farrow EG, Abdelmoity AT, Alaimo JT, Amudhavalli SM, Anderson JT, Bansal L, Bartik L, Baybayan P, Belden B, Berrios CD, Biswell RL, Buczkowicz P, Buske O, Chakraborty S, Cheung WA, Coffman KA, Cooper AM, Cross LA, Curran T, Dang TTT, Elfrink MM, Engleman KL, Fecske ED, Fieser C, Fitzgerald K, Fleming EA, Gadea RN, Gannon JL, Gelineau-Morel RN, Gibson M, Goldstein J, Grundberg E, Halpin K, Harvey BS, Heese BA, Hein W, Herd SM, Hughes SS, Ilyas M, Jacobson J, Jenkins JL, Jiang S, Johnston JJ, Keeler K, Korlach J, Kussmann J, Lambert C, Lawson C, Le Pichon JB, Leeder JS, Little VC, Louiselle DA, Lypka M, McDonald BD, Miller N, Modrcin A, Nair A, Neal SH, Oermann CM, Pacicca DM, Pawar K, Posey NL, Price N, Puckett LMB, Quezada JF, Raje N, Rowell WJ, Rush ET, Sampath V, Saunders CJ, Schwager C, Schwend RM, Shaffer E, Smail C, Soden S, Strenk ME, Sullivan BR, Sweeney BR, Tam-Williams JB, Walter AM, Welsh H, Wenger AM, Willig LK, Yan Y, Younger ST, Zhou D, Zion TN, Thiffault I, Pastinen T. Genomic answers for children: Dynamic analyses of >1000 pediatric rare disease genomes. Genet Med. 2022 06; 24(6):1336-1348.
Score: 0.021
-
Sabapathy T, Bansal R, Bojorquez L, Salley B, Gianakon JG, Gelineau-Morel R, Nyp SS. Missed Opportunities and the Impact of the Pandemic. J Dev Behav Pediatr. 2022 04 01; 43(3):176-179.
Score: 0.021
-
Wilson JL, Kim YM, O'Malley JA, Gelineau-Morel R, Gilbert L, Bain JM, Aravamuthan BR. Cerebral Palsy in Child Neurology and Neurodevelopmental Disabilities Training: An Unmet Need. J Child Neurol. 2022 03; 37(3):194-201.
Score: 0.021
-
Ng A, Galosi S, Salz L, Wong T, Schwager C, Amudhavalli S, Gelineau-Morel R, Chowdhury S, Friedman J. Failure to thrive - an overlooked manifestation of KMT2B-related dystonia: a case presentation. BMC Neurol. 2020 Jun 16; 20(1):246.
Score: 0.018
-
Vannest J, Tenney JR, Gelineau-Morel R, Maloney T, Glauser TA. Cognitive and behavioral outcomes in benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav. 2015 Apr; 45:85-91.
Score: 0.013
-
Arun T, Tomassini V, Sbardella E, de Ruiter MB, Matthews L, Leite MI, Gelineau-Morel R, Cavey A, Vergo S, Craner M, Fugger L, Rovira A, Jenkinson M, Palace J. Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. Brain. 2013 Jan; 136(Pt 1):106-15.
Score: 0.011
-
Jankovic J, Gelineau-Kattner R, Davidson A. Tourette's syndrome in adults. Mov Disord. 2010 Oct 15; 25(13):2171-5.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|